Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus

Journal of Clinical Virology

Volumn 44, Issue 1, 2009, Pages 70-73

  Springfeld, C ^a   Sauerbrei, A ^b   Filusch, A ^a   Konstandin, M ^a   Hartschuh, W ^a   Sauer, P ^a   Encke, J ^a   Stremmel, W ^a   Schnitzler, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Hepatitis; Liver failure; Vaccination; Varicella; Varicella zoster virus (VZV); VZV genotype E2

Indexed keywords

ACICLOVIR; AZATHIOPRINE; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE SEVERITY; EARLY DIAGNOSIS; EUROPE; GENOTYPE; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPTIC SHOCK; SERODIAGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE; VARICELLA ZOSTER VIRUS; VARICELLA ZOSTER VIRUS TYPE E2; VESICULAR RASH; VIRUS INFECTION; VIRUS LOAD;

ADULT; AZATHIOPRINE; BLOOD; CHICKENPOX; CROHN DISEASE; DNA, VIRAL; FATAL OUTCOME; GENOTYPE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIPLE ORGAN FAILURE; SEQUENCE ANALYSIS, DNA; SHOCK, SEPTIC; TRACHEA;

EID: 57749106339     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.10.004     Document Type: Article

References (26)

1. Breuer J., and Whitley R. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes 14 Suppl. 2 (2007) 25A-29A
2. Vossen M.T.M., Gent M.R., Peters K.M.C., Wertheim-van Dillen P.M.E., Dolman K.M., van Breda A., van Lier R.A.W., and Kuijpers T.W. Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox. J Clin Microbiol 43 (2005) 5614-5621
3. Venkatesh S.K., and Lo L.L.-L. CT appearance of varicella zoster lesions in liver and spleen in an immunocompetent patient. J Clin Virol 36 (2006) 303-305
4. Nikkels A.F., Delvenne P., Sadzot-Delvaux C., Debrus S., Piette J., Rentier B., Lipcsei G., Quatresooz P., and Piérad G.E. Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol 49 (1996) 243-248
5. Soriano V., Bru F., and Gonzalez-Lahoz J. Fatal varicella hepatitis in a patient with AIDS. J Infect 25 (1992) 107
6. Quinlivan M.L., Ayres K., Ran H., McElwaine S., Leedham-Green M., Scott F.T., Johnson R.W., and Breuer J. Effect of viral load on the outcome of herpes zoster. J Clin Microbiol 45 (2007) 3909-3914
7. David D.S., Tegtmeier B.R., O'Donnell M.R., Paz B., and McCarty T.M. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. Am J Gastroenterol 93 (1998) 810-813
8. Volpi A. Severe complications of herpes zoster. Herpes 14 Suppl. 2 (2007) 35A-39A
9. Ständige Impfkommission am Robert Koch Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand: Juli 2004. Epidemiol Bull 30:235-50.
10. Wutzler P., Färber I., Wagenpfeil S., Bisanz H., and Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 20 (2001) 121-124
11. Banz K., Wagenpfeil S., Neiss A., Hammerschmidt T., and Wutzler P. The burden of varicella in Germany. Eur J Health Econ 5 (2004) 46-53
12. Gnann Jr. J.W. Varicella-zoster virus: atypical presentations and unusual complcations. J Inf Dis 186 Suppl. 1 (2002) 891-898
13. Koskiniemi M., Piiparinen H., Rantalaiho T., Eränkö P., Färkkilä M., Räihä K., Salonen E.-M., Ukkonen P., Vaheri A., and The Study Group. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 25 (2002) 293-301
14. Patti M.E., Selvaggi K.J., and Koboth F.J. Varicella hepatitis in the immunocompromised adult: a case report and review of the literature. Am J Med 88 (1990) 77-80
15. Hirose I., Ymamaguchi H., Inaguma D., Ono K., Shimada S., Kawada J., Shiraki K., and Kimura H. Fatal varicella infection in a girl with systemic lupus erythematosus after oral acyclovir prophylaxis. Eur J Pediatr 165 (2006) 280-281
16. Dits H., Frans E., Wihner A., Van Ranst M., Fevery J., and Bobbaers H. Varicella-zoster virus infection associated with acute liver failure. Clin Inf Dis 27 (1998) 209-210
17. Sauerbrei A., Philipps A., Zell R., and Wutzler P. Genotyping of varicella-zoster virus strains after passages in cell culture. J Virol Methods 145 (2007) 80-83
18. Loparev V.N., Gonzalez A., Deleon-Carnes M., Tipples G., Fickenscher H., Torfason E.G., and Schmid D.S. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 78 (2004) 8349-8358
19. Sauerbrei A., Zell R., Philipps A., and Wutzler P. Genotypes of varicella-zoster virus wild-type strains in Germany. J Med Virol 80 (2008) 1123-1130
20. Tipples G.A., Stephens G.M., Sherlock C., Bowler M., Hoy B., Cook D., and Grose C. New variant of varicella-zoster virus. Emerg Inf Dis 8 (2002) 1504-1505
21. Natoli S., Ciotti M., Paba P., Testore G.P., Palmieri G., Orlandi A., Sabato A.F., and Leonardis F. A novel mutation of varicell-zoster virus associated to fatal hepatitis. J Clin Virol 37 (2006) 72-74
22. Gershon A.A. The current status of live attenuated varicella vaccine. Arch Virol 17 Suppl. (2001) 1-6
23. Wagenpfeil S., Neiss A., Banz K., and Wutzler P. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect 10 (2004) 425-430
24. Vazquez M., and Shapiro E.D. Varicella vaccine and infection with varicella-zoster virus. N Engl J Med 352 (2005) 439-440
25. Davis M.M., Patel M.S., and Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114 (2004) 786-792
26. Theodoridou M., Laina I., Hadjichristodoulou C., and Syriopoulou V. Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction. Eur J Pediatr 165 (2006) 273-274